Art

J-GLOBAL ID：202002281411509544   Reference number：20A0025249

Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study

術前化学放射線療法を行わない高リスクステージIIおよびステージIII直腸癌の治療を受けた患者に対する術後XELOX療法:前向き,多施設,オープンラベル,単腕第II相試験【JST・京大機械翻訳】

Author (22)： Mizushima Tsunekazu (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Mizushima Tsunekazu (Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Ikeda Masataka (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Ikeda Masataka (Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Ikeda Masataka (Division of Lower GI Surgery, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan) ,  Ikeda Masataka (Department of Surgery, National Hospital Organization, Osaka, Japan) ,  Kato Takeshi (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Kato Takeshi (Department of Surgery, National Hospital Organization, Osaka, Japan) ,  Ikeda Atsuyo (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Ikeda Atsuyo (Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Nishimura Junichi (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Nishimura Junichi (Department of Gastroenterological Surgery, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Osaka, Japan) ,  Hata Taishi (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Hata Taishi (Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan) ,  Matsuda Chu (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Matsuda Chu (Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Satoh Taroh (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Satoh Taroh (Department of Frontier-Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Mori Masaki (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Mori Masaki (Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan) ,  Doki Yuichiro (Multi-Center Clinical Study Group of Osaka University, Colorectal Group (MCSGO), Osaka, Japan) ,  Doki Yuichiro (Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan)
Material： BMC Cancer (Web)
Volume： 19  Issue： 1  Page： 1-8  Publication year： 2019 
JST Material Number： U7305A  ISSN： 1471-2407  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Preoperative 5-FU-based chemor...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0025249&from=J-GLOBAL&jstjournalNo=U7305A") }}

Thesaurus term： sphincter ,  *phase 2 study ,  man ,  effectiveness ,  clinical trial ,  woman ,  colonic neoplasm ,  tumor ,  *Rectum ,  side effect ,  *rectal neoplasm ,  confidence interval ,  *radiochemotherapy
Semi thesaurus term： オキサリプラチン ,  局所再発 , 【Automatic Indexing@JST】

JST classification (1)： Tumors(=neoplasms)of digestive system  (GH04000D)

Reference (26)：

• N Engl J Med; Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer; T Andre, C Boni, L Mounedji-Boudiaf, M Navarro, J Tabernero, T Hickish, C Topham, M Zaninelli, P Clingan, J Bridgewater, I Tabah-Fisch, A Gramont; 350; 23; 2004; 2343-2351; 10.1056/NEJMoa032709; citation_id=CR1
• J Clin Oncol Off J Am Soc Clin Oncol; Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07; JP Kuebler, HS Wieand, MJ O'Connell, RE Smith, LH Colangelo, G Yothers, NJ Petrelli, MP Findlay, TE Seay, JN Atkins, JL Zapas, JW Goodwin, L Fehrenbacher, RK Ramanathan, BA Conley, PJ Flynn, G Soori, LK Colman, EA Levine, KS Lanier, N Wolmark; 25; 16; 2007; 2198-2204; 10.1200/JCO.2006.08.2974; citation_id=CR2
• J Clin Oncol Off J Am Soc Clin Oncol; Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer; DG Haller, J Tabernero, J Maroun, F Braud, T Price, E Cutsem, M Hill, F Gilberg, K Rittweger, HJ Schmoll; 29; 11; 2011; 1465-1471; 10.1200/JCO.2010.33.6297; citation_id=CR3
• Br J Cancer; An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer; J Sakamoto, C Hamada, S Yoshida, S Kodaira, M Yasutomi, T Kato, K Oba, H Nakazato, S Saji, Y Ohashi; 96; 8; 2007; 1170-1177; 10.1038/sj.bjc.6603686; citation_id=CR4
• Ann Oncol; UFT (tegafur-uracil) in rectal cancer; E Casado, P Pfeiffer, J Feliu, M Gonzalez-Baron, L Vestermark, HA Jensen; 19; 8; 2008; 1371-1378; 10.1093/annonc/mdn067; citation_id=CR5

Terms in the title (11)： 術前化学放射線療法 ,  リスク ,  ステージ ,  直腸癌 ,  治療 ,  患者 ,  XELOX療法 ,  施設 ,  ラベル ,  腕 ,  第II相試験